Statistics

Total Visits

Views
A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph plus CML or relapsed/refractory Ph plus ALL 366

Total Visits per Month

September 2018 October 2018 November 2018 December 2018 January 2019 February 2019 March 2019
A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph plus CML or relapsed/refractory Ph plus ALL 0 3 12 5 2 0 1

File Downloads

Views

Top Country Views

Views
United States 124
Australia 22
China 20
France 7
Colombia 3
Ukraine 3
United Kingdom 2
Japan 2
Germany 1
India 1

Top City Views

Views
Mountain View 78
Kaleen 17
Baltimore 9
Beijing 6
Bogotá 3
Adelaide 2
Canberra 2
Jacksonville 2
Southampton 2
Bangalore 1